Reports: ZORA Program (Slovenia): Difference between revisions

From Beacon
(Created page with "{{#subobject:ZORA Program |dct:title=ZORA Program |datatype=policymaking }} '''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program. '''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years. '''Type of information:''' The percentage of women in the target group who are...")
 
No edit summary
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{#subobject:ZORA Program
<span style="display:none">forpolicymakers</span>
|dct:title=ZORA Program
<span style="display:none">sloveniacountry</span>
|datatype=policymaking
Go back to [[Slovenia]] page
}}


'''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program.  
'''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
 
'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]].
 
'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines ([[availableVariable::screening]]); The number of new patients in a given year; (RMV [[availableVariable::cancer incidence|incidence]] rate); [[availableVariable::number of deaths|Mortality]] due to RMV; [[availableVariable::causes of death]]; The ratio between the number of newly detected precancerous and cancerous changes per [[availableVariable::year]]. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more].


'''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
'''Data level:''' [[dataLevel::national level]].


'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year.
'''Cancer areas of interest:''' [[hasCancerType::C51-C58: Female genitalia cancer]]. [https://zora.onko-i.si/program-zora/namen-in-cilji Click here to learn more].


'''Data level:''' National level.
'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access].


'''Access to information:''' Access Information [https://zora.onko-i.si/publikacije/letna-porocila].
<span style="display:none">Vulva</span>
<span style="display:none">Vagina</span>
<span style="display:none">Cervix</span>
<span style="display:none">Uterus</span>
<span style="display:none">Ovary</span>
<span style="display:none">Fallopian tubes</span>
<span style="display:none">Endometrium</span>
<span style="display:none">dataOwner::Ljubljana Oncology Institute</span>
<span style="display:none">dataOwner::ZORA Program</span>
<span style="display:none">availableVariable::screening</span>
<span style="display:none">availableVariable::cancer incidence|incidence</span>
<span style="display:none">availableVariable::number of deaths|Mortality</span>
<span style="display:none">availableVariable::causes of death</span>
<span style="display:none">availableVariable::year</span>
<span style="display:none">dataLevel::national level</span>
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span>
<span style="display:none">isReport</span>

Latest revision as of 16:48, 4 December 2025

forpolicymakers sloveniacountry Go back to Slovenia page

Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.

Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.

Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; causes of death; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.

Data level: national level.

Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.

Access to information: Click here to access.

Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium dataOwner::Ljubljana Oncology Institute dataOwner::ZORA Program availableVariable::screening availableVariable::cancer incidence|incidence availableVariable::number of deaths|Mortality availableVariable::causes of death availableVariable::year dataLevel::national level hasCancerType::C51-C58: Female genitalia cancer isReport